Identity and percentage holding of significant shareholders
Substantial holdings | Shares held | % |
---|---|---|
Directors and related shareholders | ||
Ian Gilham | 614,295 | 0.43% |
Gino Miele | 66,979 | 0.05% |
Tom Lindsay | 262,717 | 0.18% |
Chris Yates | 67,554 | 0.05% |
Total Directors' holdings | 1,011,545 | 0.71% |
Total shares in issue | 143,141,481 | 100.00% |
Shareholder information
genedrive shares are quoted and traded on the AIM market of the London Stock Exchange.
Authorised Share Capital: No authorised maximum number of shares are required. There are no shares held in treasury and there are no restrictions on transfer.
Issued Share Capital: The total number of genedrive plc ordinary shares of 1.5p each in issue is 118,789,946.
Number of AIM securities not in public hands is 1,011,545 or 0.71%.
Text updated: 11/04/2024
Latest reports
05 April 2024
Interim Presentation 31 December 2023
Investor News
Monday February 19, 2024
Genedrive eyes funding in aim of NHS recommendation
Wednesday February 03, 2021
Genedrive close to hitting the market with coronavirus tests
Friday December 22, 2023